Antibodies - Targeting Checkpoint Proteins on NK Cells
Can't see this email? View it online
   
  Antibodies  
  The latest antibodies news from News Medical  
 

Accelerating Antibody Discovery with Polyclonal Antibody SequencingAccelerating Antibody Discovery with Polyclonal Antibody Sequencing

Antibodies have revolutionized the treatment landscape in human and veterinary medicine. Novel antibody discovery modalities such as polyclonal antibody sequencing, provide the ability to leverage functional, circulating antibodies directly from the native immune system for therapeutic development.

Accelerate your Antibody Discovery
 
 
    Targeting Checkpoint Proteins on NK CellsTargeting Checkpoint Proteins on NK Cells
 
NK cells have been shown to independently eliminate cancers, making them a promising target for immunotherapies. They are a promising therapeutic focus, especially against chemotherapy-resistant cancers.

Maintaining the equilibrium between inhibitory and activating signals is pivotal for NK cell function. ACROBiosystems offers NK cell immune checkpoint proteins to aid drug and therapy development

 
Find your NK Cell Reagents
 
 
   Man-made antibody successfully prevents organ rejection after transplantationMan-made antibody successfully prevents organ rejection after transplantation
 
A man-made antibody successfully prevented organ rejection when tested in primates that had undergone a kidney transplant, Duke Health researchers report.
 
 New machine-learning algorithms can help optimize the next-generation of therapeutic antibodies
 
New machine-learning algorithms can help optimize the next-generation of therapeutic antibodiesAntibody treatments may be able to activate the immune system to fight diseases like Parkinson’s, Alzheimer’s and colorectal cancer, but they are less effective when they bind with themselves and other molecules that aren’t markers of disease.
 
 
 Inactivated poliovirus vaccine elicits persistent immunity for up to 10 years
 
Inactivated poliovirus vaccine elicits persistent immunity for up to 10 yearsThe neutralizing antibodies persistence of the Sabin strain-derived inactivated poliovirus vaccine.
 
 
 Study identifies a molecule that may be behind COVID-19 brain fog
 
Study identifies a molecule that may be behind COVID-19 brain fogA study identifies a molecule that may be behind cognitive symptoms, including "brain fog," experienced by those infected by the SARS-CoV-2 virus.
 
 
 Phase 3 study: The efficacy of monovalent SARS-CoV-2 vaccine with AS03 adjuvant in adults
 
Phase 3 study: The efficacy of monovalent SARS-CoV-2 vaccine with AS03 adjuvant in adultsThe effectiveness of a novel monovalent recombinant protein vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).